Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0535USD
−6.58 MUSD
47.02 M
About Nymox Pharmaceutical Corp.
Sector
CEO
Paul Averback
Headquarters
Nassau
Website
Founded
1995
FIGI
BBG000FYJ221
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NYMXF is 0.2395 USD — it has increased by 18.27% in the past 24 hours. Watch Nymox Pharmaceutical Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nymox Pharmaceutical Corp. stocks are traded under the ticker NYMXF.
NYMXF stock has risen by 99.58% compared to the previous week, the month change is a 14.10% rise, over the last year Nymox Pharmaceutical Corp. has showed a 29.56% decrease.
NYMXF reached its all-time high on Mar 17, 1998 with the price of 13.6250 USD, and its all-time low was 0.0501 USD and was reached on Jun 13, 2024. View more price dynamics on NYMXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NYMXF stock is 29.46% volatile and has beta coefficient of −2.50. Track Nymox Pharmaceutical Corp. stock price on the chart and check out the list of the most volatile stocks — is Nymox Pharmaceutical Corp. there?
Today Nymox Pharmaceutical Corp. has the market capitalization of 21.86 M, it has increased by 37.76% over the last week.
Yes, you can track Nymox Pharmaceutical Corp. financials in yearly and quarterly reports right on TradingView.
Nymox Pharmaceutical Corp. is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
NYMXF net income for the last quarter is −1.04 M USD, while the quarter before that showed −1.11 M USD of net income which accounts for 6.67% change. Track more Nymox Pharmaceutical Corp. financial stats to get the full picture.
No, NYMXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NYMXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nymox Pharmaceutical Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nymox Pharmaceutical Corp. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nymox Pharmaceutical Corp. stock shows the sell signal. See more of Nymox Pharmaceutical Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.